Lexeo Therapeutics Inc (NAS:LXEO)
$ 4.64 -0.16 (-3.33%) Market Cap: 364.34 Mil Enterprise Value: 179.05 Mil PE Ratio: 0 PB Ratio: 1.48 GF Score: 10/100

Lexeo Therapeutics Inc at RBC Capital Markets Global Healthcare Conference Transcript

May 19, 2026 / 06:35 PM GMT
Release Date Price: $4.48 (-4.88%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

LXEO.OQ - Lexeo Therapeutics Inc
Lexeo Therapeutics Inc at RBC Capital Markets Global Healthcare Conference
May 19, 2026 / 06:35PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
RBC Capital Market. Today is our great privilege to have Lexia Therapeutics as part of our 2026 Global Healthcare Conference. Representing the company, we have Nolan Townsend, Chief Executive Officer, as well as Nadi Bahalla, who is the Chief Medical Officer here. I appreciate everyone joining here. I have a long list of questions here, Nolan, but maybe before we go into the specifics, you'll be fantastic if you can maybe just give us a little bit of an overview. Of what progress has the organization made over the last few months, and maybe most importantly, what's ahead here for Lexio?

--------------------------------------------------------------------------------
Unidentified_2 [2]
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot